Synthomer (SYNT) Competitors GBX 169.60 -1.40 (-0.82%) (As of 11:36 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider Trades SYNT vs. VCT, ELM, ESNT, SCPA, TET, ZTF, IOF, WCH, ITX, and DCTAShould you be buying Synthomer stock or one of its competitors? The main competitors of Synthomer include Victrex (VCT), Elementis (ELM), Essentra (ESNT), Scapa Group (SCPA), Treatt (TET), Zotefoams (ZTF), Iofina (IOF), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), and Directa Plus (DCTA). These companies are all part of the "specialty chemicals" industry. Synthomer vs. Victrex Elementis Essentra Scapa Group Treatt Zotefoams Iofina Wilmcote Holdings plc (WCH.L) Itaconix Directa Plus Victrex (LON:VCT) and Synthomer (LON:SYNT) are both small-cap basic materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, community ranking, media sentiment, earnings, dividends and risk. Is VCT or SYNT a better dividend stock? Victrex pays an annual dividend of GBX 60 per share and has a dividend yield of 5.4%. Synthomer pays an annual dividend of GBX 25 per share and has a dividend yield of 14.7%. Victrex pays out 17,142.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Synthomer pays out -4,098.4% of its earnings in the form of a dividend. Synthomer is clearly the better dividend stock, given its higher yield and lower payout ratio. Which has more risk and volatility, VCT or SYNT? Victrex has a beta of 0.69, indicating that its share price is 31% less volatile than the S&P 500. Comparatively, Synthomer has a beta of 1.79, indicating that its share price is 79% more volatile than the S&P 500. Do analysts recommend VCT or SYNT? Victrex currently has a consensus price target of GBX 1,425, suggesting a potential upside of 29.31%. Synthomer has a consensus price target of GBX 288.33, suggesting a potential upside of 70.01%. Given Synthomer's stronger consensus rating and higher possible upside, analysts clearly believe Synthomer is more favorable than Victrex.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Victrex 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Synthomer 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Which has better earnings and valuation, VCT or SYNT? Victrex has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Victrex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVictrex£284.10M3.38£30.70M£0.353,148.57Synthomer£1.97B0.14-£83.30M-£0.61-278.03 Do institutionals & insiders have more ownership in VCT or SYNT? 97.1% of Victrex shares are held by institutional investors. Comparatively, 43.8% of Synthomer shares are held by institutional investors. 1.6% of Victrex shares are held by company insiders. Comparatively, 28.0% of Synthomer shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community prefer VCT or SYNT? Synthomer received 219 more outperform votes than Victrex when rated by MarketBeat users. Likewise, 68.49% of users gave Synthomer an outperform vote while only 63.61% of users gave Victrex an outperform vote. CompanyUnderperformOutperformVictrexOutperform Votes50763.61% Underperform Votes29036.39% SynthomerOutperform Votes72668.49% Underperform Votes33431.51% Is VCT or SYNT more profitable? Victrex has a net margin of 10.81% compared to Synthomer's net margin of -4.33%. Victrex's return on equity of 6.36% beat Synthomer's return on equity.Company Net Margins Return on Equity Return on Assets Victrex10.81% 6.36% 6.59% Synthomer -4.33%-7.90%-0.28% Does the media refer more to VCT or SYNT? In the previous week, Victrex had 8 more articles in the media than Synthomer. MarketBeat recorded 9 mentions for Victrex and 1 mentions for Synthomer. Victrex's average media sentiment score of 0.50 beat Synthomer's score of 0.00 indicating that Victrex is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Victrex 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Synthomer 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryVictrex and Synthomer tied by winning 10 of the 20 factors compared between the two stocks. Ad Banyan Hill PublishingStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute he steps back into the White House. Because if what’s in this leaked document is even half true (and trust me, it comes from a very, very credible source)... I put all the details together for you here — but please hurry. Get Synthomer News Delivered to You Automatically Sign up to receive the latest news and ratings for SYNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SYNT vs. The Competition Export to ExcelMetricSynthomerSpecialty Chemicals IndustryMaterials SectorLON ExchangeMarket Cap£277.42M£7.81B£2.79B£1.42BDividend Yield28.47%4.02%5.26%11.77%P/E Ratio-278.03302.71120.341,573.59Price / Sales0.14464.45947,531.63343,314.10Price / Cash2.2818.0223.3232.92Price / Book0.255.053.462.83Net Income-£83.30M£133.33M£146.11M£153.14M7 Day Performance0.59%0.96%6.46%4.35%1 Month Performance-5.15%-3.33%7.45%19.63%1 Year Performance-6.25%-11.09%25.41%20.36% Synthomer Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SYNTSynthomer2.2502 of 5 starsGBX 169.60-0.8%GBX 288.33+70.0%-5.5%£277.42M£1.97B-278.034,200News CoverageVCTVictrex2.8576 of 5 starsGBX 1,094.09-0.2%GBX 1,425+30.2%-25.8%£952.19M£284.10M3,131.431,109Dividend IncreaseHigh Trading VolumeELMElementisN/AGBX 138.40-0.3%GBX 173.33+25.2%+16.3%£815.34M£732.20M-3,460.001,281Gap UpESNTEssentra1.9835 of 5 starsGBX 148+0.3%GBX 216.67+46.4%-1.3%£424.97M£309.70M7,980.00350Gap DownSCPAScapa GroupN/AGBX 214.50flatN/A+0.0%£402.98M£281.80M-7.321,461TETTreatt2.3385 of 5 starsGBX 475flatGBX 675+42.1%+13.1%£288.42M£143.55M2,638.89350Dividend IncreaseNews CoverageZTFZotefoamsN/AGBX 342-3.1%N/A+6.9%£166.21M£133.40M1,765.00549News CoverageIOFIofina2.7539 of 5 starsGBX 19.07+1.6%GBX 35+83.6%-20.8%£36.58M£51.71M1,900.0095WCHWilmcote Holdings plc (WCH.L)N/AGBX 3flatN/A+0.0%£20.13MN/A-5.003ITXItaconixN/AGBX 122-2.2%N/A-7.9%£16.46M£6.62M-3,150.0017Gap DownDCTADirecta PlusN/AGBX 8.05flatN/A-70.0%£8.41M£9.33M-137.50187High Trading Volume Related Companies and Tools Related Companies Victrex Alternatives Elementis Alternatives Essentra Alternatives Scapa Group Alternatives Treatt Alternatives Zotefoams Alternatives Iofina Alternatives Wilmcote Holdings plc (WCH.L) Alternatives Itaconix Alternatives Directa Plus Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:SYNT) was last updated on 12/10/2024 by MarketBeat.com Staff From Our PartnersBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | SponsoredVanguard issues correction warningThe S&P just notched another record close... Apple and Meta are leading the Nasdaq to extraordinary new hei...Chaikin Analytics | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThe Death Knell for U.S. StocksThey are among the 31 billionaires dumping their stocks at a record pace. Fortune calls this phenomenon "Th...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synthomer plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Synthomer With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.